A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181

Summary

An open-label phase I clinical study,which enrolled subjects with advanced solid tumors who have failed to respond to adequate standard therapies or have no available effective standard therapy.

Timeline

Start

2025-12-03

Primary completion

2026-08

Completion

2027-08

Drugs

Indications